Summary of Classification and Labelling
Notified classification and labelling
General Information
629-893-0 |
N~1~-{3-fluoro-4-[(6-(methyloxy)-7-{[3-(4-morpholinyl)propyl]oxy}-4-quinolinyl)oxy]phenyl}-N~1~-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide |
849217-64-7 |
Notified classification and labelling according to CLP criteria
Acute Tox. 4 |
H302
|
H302
|
|
GHS07 GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
STOT RE 2 |
H373
(adrenal glands,...)
(oral)
|
H373
(adrenal glands,...)
|
STOT RE 2 |
H373
(other:adrenal g...)
(oral)
|
H373
(adrenal glands,...)
|
Acute Tox. 4 |
H302
|
H302
|
|
GHS07 GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
STOT RE 2 |
H373
(bone marrow)
|
H373
(bone marrow)
|
Number of Aggregated Notifications: 2